Biotech’s Next Goal: ‘Addressing Resistance’ In The ADC Space

Indispensable Value Of Partnerships Discussed by German Biopharma

George Badescu, chief business officer at Heidelberg Pharma, discusses antibody-drug conjugate development, partnership styles and the appetite for risk-taking in the biopharma industry.

Partnerships On The Rise • Source: Shutterstock

The cruciality of partnerships in business was stressed by George Badescu, chief business officer (CBO) at oncology therapies company Heidelberg Pharma AG, during a talk at the BIO-Europe Spring conference.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Growth

More from In Vivo